2024 asa guidance glp-1 receptor agonists perioperative RA roundup Perioperative management of patients taking
Description
Additionally, several key clinical trial readouts delivered compelling data across multiple indications, for example (see Figure 1): Semaglutide: STEP-HFpEF (functional benefits in HFpEF), STEP-9 (pain reduction in knee osteoarthritis), STEP-10 (reversion to normoglycaemia in pre-diabetic, obese patients), ESSENCE (resolution of MASH, improvement in fibrosis) Tirzepatide: SUMMIT (risk reduction in HFpEF outcomes

About one in eight adults (12%) say that they are currently taking a GLP-1 drug such as Ozempic or Wegovy either to lose weight or treat a chronic condition, an increase from 18 months ago, though the high costs of the medications remain a concern, a new KFF Health Tracking Poll finds.

Next up: glucagon-like peptide 1 receptor agonists, known colloquially (and identified here) as GLPs

Discover how this sugar may boost GLP-1, reduce body fat, and support long-term metabolic health.
Could it be because Indian physicians are conservative when it comes to prescribing newer drugs

The list of conditions for which GLP-1 drugs provides benefit independent of weight loss keeps growing